Ieq Capital LLC Acquires New Position in Varex Imaging Co. (NASDAQ:VREX)

Ieq Capital LLC acquired a new stake in Varex Imaging Co. (NASDAQ:VREX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 21,012 shares of the company's stock, valued at approximately $307,000. Ieq Capital LLC owned 0.05% of Varex Imaging as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. FMR LLC raised its holdings in Varex Imaging by 4,739.2% in the third quarter. FMR LLC now owns 200,341 shares of the company's stock valued at $2,388,000 after acquiring an additional 196,201 shares in the last quarter. Barclays PLC raised its holdings in shares of Varex Imaging by 15.3% in the 3rd quarter. Barclays PLC now owns 97,883 shares of the company's stock valued at $1,166,000 after purchasing an additional 12,966 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Varex Imaging by 37.3% in the 3rd quarter. Assenagon Asset Management S.A. now owns 185,506 shares of the company's stock valued at $2,211,000 after purchasing an additional 50,382 shares in the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Varex Imaging during the 3rd quarter worth $415,000. Finally, BNP Paribas Financial Markets grew its stake in shares of Varex Imaging by 1,359.9% during the third quarter. BNP Paribas Financial Markets now owns 52,295 shares of the company's stock worth $623,000 after purchasing an additional 48,713 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on VREX. B. Riley reaffirmed a "buy" rating and set a $22.00 price target (up from $21.00) on shares of Varex Imaging in a report on Friday, February 7th. StockNews.com upgraded Varex Imaging from a "hold" rating to a "buy" rating in a research note on Friday, February 7th. Finally, Oppenheimer dropped their price target on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research note on Friday, February 7th.

Remove Ads

Varex Imaging Stock Performance

NASDAQ VREX traded down $0.03 during trading hours on Monday, hitting $12.83. The company had a trading volume of 256,437 shares, compared to its average volume of 500,270. The business has a 50 day moving average of $13.77 and a 200-day moving average of $13.39. The company has a market cap of $528.64 million, a PE ratio of -10.97 and a beta of 0.62. Varex Imaging Co. has a 1-year low of $10.19 and a 1-year high of $18.30. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, equities research analysts expect that Varex Imaging Co. will post 0.53 EPS for the current year.

Varex Imaging Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.